Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.verified

KKPCF

Price:

$24

Market Cap:

$142.39B

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatm...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-09

Stock Exchange

OTC

Ticker

KKPCF

The Enterprise Value as of December 2025 (TTM) for Kaken Pharmaceutical Co., Ltd. (KKPCF) is 90.83B

According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 90.83B. This represents a change of -11.70% compared to the average of 102.87B of the last 4 quarters.

Kaken Pharmaceutical Co., Ltd. (KKPCF) Historical Enterprise Value (quarterly & annually)

How has KKPCF Enterprise Value performed in the past?

The mean historical Enterprise Value of Kaken Pharmaceutical Co., Ltd. over the last ten years is 148.66B. The current 90.83B Enterprise Value has changed 6.01% with respect to the historical average. Over the past ten years (40 quarters), KKPCF's Enterprise Value was at its highest in in the September 2015 quarter at 451.00B. The Enterprise Value was at its lowest in in the December 2023 quarter at 79.45B.

Quarterly (TTM)
Annual

Average

148.66B

Median

130.88B

Minimum

83.11B

Maximum

257.18B

Kaken Pharmaceutical Co., Ltd. (KKPCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 43.66%

Maximum Annual Enterprise Value = 257.18B

Minimum Annual Increase = -24.17%

Minimum Annual Enterprise Value = 83.11B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025120.76B43.66%
202484.06B1.14%
202383.11B-8.22%
202290.56B-15.71%
2021107.43B-23.81%
2020141.00B-12.68%
2019161.47B-24.17%
2018212.93B-6.62%
2017228.04B-11.33%
2016257.18B-9.78%

Kaken Pharmaceutical Co., Ltd. (KKPCF) Average Enterprise Value

How has KKPCF Enterprise Value performed in the past?

The current Enterprise Value of Kaken Pharmaceutical Co., Ltd. (KKPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

95.98B

5-year avg

97.19B

10-year avg

148.66B

Kaken Pharmaceutical Co., Ltd. (KKPCF) Enterprise Value vs. Peers

How is KKPCF’s Enterprise Value compared to its peers?

Kaken Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Luye Pharma Group Ltd. (15.21B), greater than China Shineway Pharmaceutical Group Limited (-697447501.20), greater than Adcock Ingram Holdings Limited (11.12B), greater than Drägerwerk AG & Co. KGaA (1.55B), greater than TerrAscend Corp. (395.19M), less than PT Tempo Scan Pacific Tbk (9.10T), greater than Biotest AG (2.02B), greater than Kossan Rubber Industries Bhd (1.93B), greater than Columbia Care Inc. (647.98M), greater than Biotage AB (publ) (11.28B),

Build a custom stock screener for Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Kaken Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the 3-year average Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the 5-year average Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

How does the current Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF) compare to its historical average?